Literature DB >> 6610841

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

G McKhann, D Drachman, M Folstein, R Katzman, D Price, E M Stadlan.   

Abstract

Clinical criteria for the diagnosis of Alzheimer's disease include insidious onset and progressive impairment of memory and other cognitive functions. There are no motor, sensory, or coordination deficits early in the disease. The diagnosis cannot be determined by laboratory tests. These tests are important primarily in identifying other possible causes of dementia that must be excluded before the diagnosis of Alzheimer's disease may be made with confidence. Neuropsychological tests provide confirmatory evidence of the diagnosis of dementia and help to assess the course and response to therapy. The criteria proposed are intended to serve as a guide for the diagnosis of probable, possible, and definite Alzheimer's disease; these criteria will be revised as more definitive information become available.

Entities:  

Mesh:

Year:  1984        PMID: 6610841     DOI: 10.1212/wnl.34.7.939

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2000 in total

1.  The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease.

Authors:  M Y Aksenov; H M Tucker; P Nair; M V Aksenova; D A Butterfield; S Estus; W R Markesbery
Journal:  Neurochem Res       Date:  1999-06       Impact factor: 3.996

2.  White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging.

Authors:  R Barber; P Scheltens; A Gholkar; C Ballard; I McKeith; P Ince; R Perry; J O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

Review 3.  Acetylcholinesterase inhibitors in Alzheimer's disease.

Authors:  B M McGleenon; K B Dynan; A P Passmore
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

Review 4.  Ethnicity and dementia.

Authors:  D G Harwood; R L Ownby
Journal:  Curr Psychiatry Rep       Date:  2000-02       Impact factor: 5.285

5.  Sense of coherence buffers relationships of chronic stress with fasting glucose levels.

Authors:  J Zhang; P P Vitaliano; S K Lutgendorf; J M Scanlan; M V Savage
Journal:  J Behav Med       Date:  2001-02

6.  Quantitative electroencephalography in Alzheimer's disease: comparison with a control group, population norms and mental status.

Authors:  V Knott; E Mohr; C Mahoney; V Ilivitsky
Journal:  J Psychiatry Neurosci       Date:  2001-03       Impact factor: 6.186

7.  Both total and phosphorylated tau are increased in Alzheimer's disease.

Authors:  M Sjögren; P Davidsson; M Tullberg; L Minthon; A Wallin; C Wikkelso; A K Granérus; H Vanderstichele; E Vanmechelen; K Blennow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

8.  Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: patterns of functional MRI activation.

Authors:  A J Saykin; L A Flashman; S A Frutiger; S C Johnson; A C Mamourian; C H Moritz; J R O'Jile; H J Riordan; R B Santulli; C A Smith; J B Weaver
Journal:  J Int Neuropsychol Soc       Date:  1999-07       Impact factor: 2.892

9.  Family physicians take on new dementia guidelines.

Authors:  G Worrall; D Gass; S Wetmore; J Feightner
Journal:  Can Fam Physician       Date:  1999-09       Impact factor: 3.275

10.  Update on Alzheimer's disease: recent findings and treatments.

Authors:  R O'Hara; M S Mumenthaler; J A Yesavage
Journal:  West J Med       Date:  2000-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.